Related Articles
HER2 overexpression reverses the relative resistance of EGFR-mutant H1975 cell line to gefitinib
Tendencies for higher co-expression of EGFR and HER2 and downregulation of HER3 in prostate cancer lymph node metastases compared with corresponding primary tumors
Biomarkers for predicting response to tyrosine kinase inhibitors in drug-sensitive and drug-resistant human bladder cancer cells
PD-L1 mRNA expression in EGFR-mutant lung adenocarcinoma
Enhanced antitumor activity of trastuzumab emtansine (T-DM1) in combination with pertuzumab in a HER2-positive gastric cancer model